Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade

द्वारा Ribnikar, Domen, Goldvaser, Hadar, Veitch, Zachary W., Ocana, Alberto, Templeton, Arnoud J., Šeruga, Boštjan, Amir, Eitan
में प्रकाशित Sci Rep (2021)

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

द्वारा Hembruff, Stacey L, Laberge, Monique L, Villeneuve, David J, Guo, Baoqing, Veitch, Zachary, Cecchetto, Melanie, Parissenti, Amadeo M
प्रकाशित 2008

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program

द्वारा Veitch, Zachary W., Fasih, Samir, Griffin, Anthony M., Al‐Ezzi, Esmail M., Gupta, Abha A., Ferguson, Peter C., Wunder, Jay S., Abdul Razak, Albiruni R.
में प्रकाशित Cancer Med (2020)

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)

द्वारा Veitch, Zachary, Zer, Alona, Loong, Herbert, Salah, Samer, Masood, Maryam, Gupta, Abha, Bradbury, Penelope A., Hogg, David, Wong, Andrew, Kandel, Rita, Charames, George S., Abdul Razak, Albiruni R.
में प्रकाशित Sci Rep (2019)

Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Ou...

द्वारा Albaba, Hamzeh, Barnes, Tristan A., Veitch, Zachary, Brown, M. Catherine, Shakik, Sharara, Su, Susie, Naik, Hiten, Wang, Tian, Liang, Mindy, Perez‐Cosio, Andrea, Eng, Lawson, Mittmann, Nicole, Xu, Wei, Howell, Doris, Liu, Geoffrey
में प्रकाशित Oncologist (2019)

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

द्वारा Veitch, Zachary W., Cescon, David W., Denny, Trisha, Yonemoto, Lisa-Maria, Fletcher, Graham, Brokx, Richard, Sampson, Peter, Li, Sze-Wan, Pugh, Trevor J., Bruce, Jeffrey, Bray, Mark R., Slamon, Dennis J., Mak, Tak W., Wainberg, Zev A., Bedard, Philippe L.
में प्रकाशित Br J Cancer (2019)